ITEOS THERAPEUTICS, INC. : Other Events (form 8-K)

Item 8.01 Other Events.

On July 26, 2021, iTeos Belgium S.A., an affiliate of iTeos Therapeutics, Inc. (collectively, "iTeos") and GlaxoSmithKline Intellectual Property (No. 4) Limited closed the transactions contemplated by that certain Collaboration and License Agreement, dated as of June 11, 2021 (the "Collaboration Agreement").

iTeos previously disclosed the entry into the Collaboration Agreement in its Current Report on Form 8-K, filed with the Securities and Exchange Commission on June 14, 2021. Additional details regarding the transactions contemplated by the Collaboration Agreement can be found therein.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses